Patents Assigned to Singulex, Inc.
  • Publication number: 20130252346
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin, Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 26, 2013
    Applicant: SINGULEX, INC.
    Inventors: Philippe Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Allan H.B. Wu
  • Patent number: 8535895
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: September 17, 2013
    Assignees: Singulex, Inc., The Regents of the University of California
    Inventors: Philippe Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Allan H. B. Wu
  • Patent number: 8462339
    Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: June 11, 2013
    Assignee: Singulex, Inc.
    Inventor: Richard Livingston
  • Patent number: 8450069
    Abstract: Cardiovascular disease, e.g., congestive heart failure, is often first diagnosed after the onset of clinical symptoms, eliminating potential for early intervention. The invention provides a multi-marker immunoassay, including cardiac pathology and vascular inflammation biomarkers, yielding a more sensitive assay for early detection of CHF in plasma. A panel consisting of cardiac pathology (cTnI, BNP) and vascular inflammation (IL-6, TNF?, IL-17a) biomarkers provided a sensitivity of 94% for association with CHF.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: May 28, 2013
    Assignee: Singulex, Inc.
    Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Sara Le
  • Publication number: 20130130403
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 23, 2013
    Applicant: SINGULEX, INC.
    Inventor: SINGULEX, INC.
  • Publication number: 20130059400
    Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.
    Type: Application
    Filed: September 10, 2012
    Publication date: March 7, 2013
    Applicant: SINGULEX, INC.
    Inventor: Richard A. Livingston
  • Patent number: 8343728
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Grant
    Filed: October 12, 2010
    Date of Patent: January 1, 2013
    Assignees: Singulex, Inc., The Regents of the University of California
    Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held, Alan Wu
  • Patent number: 8264684
    Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: September 11, 2012
    Assignee: Singulex, Inc.
    Inventor: Richard Livingston
  • Publication number: 20110301053
    Abstract: Disclosed are methods for diagnosing, staging, and predicting risk for developing rheumatoid arthritis and other inflammatory diseases, and methods for identifying treatment responders and non-responders.
    Type: Application
    Filed: May 6, 2011
    Publication date: December 8, 2011
    Applicant: SINGULEX, INC.
    Inventors: John Allan Todd, Quynh Anh Thuc Lu, Sara Jane Le
  • Publication number: 20110263043
    Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.
    Type: Application
    Filed: February 22, 2011
    Publication date: October 27, 2011
    Applicant: SINGULEX, INC.
    Inventor: Richard A. Livingston
  • Publication number: 20110111524
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Application
    Filed: October 12, 2010
    Publication date: May 12, 2011
    Applicant: SINGULEX, INC.
    Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held, Alan Wu
  • Patent number: 7914734
    Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: March 29, 2011
    Assignee: Singulex, Inc.
    Inventor: Richard A. Livingston
  • Publication number: 20100329929
    Abstract: Disclosed are methods, kits, and compositions for the highly sensitive detection of molecules. The methods, kits, and compositions are useful in determining concentrations of molecules in samples to levels of 1 femtomolar, 1 attomolar, or lower. The methods, kits, and compositions also allow the determination of concentration over a wide range, e.g., 7-log range, without need for sample dilution.
    Type: Application
    Filed: March 25, 2010
    Publication date: December 30, 2010
    Applicant: SINGULEX, INC.
    Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held
  • Patent number: 7838250
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Grant
    Filed: April 3, 2008
    Date of Patent: November 23, 2010
    Assignees: Singulex, Inc., The Regents of the University of California
    Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held, Alan Wu
  • Publication number: 20100112727
    Abstract: The present invention provides single molecule analyses of species of use in analytical, diagnostic or prognostic assays. In exemplary embodiments, the assays utilize samples prepared by novel methods, affording assays of unexpected sensitivity and robustness. The method is described in a non-limiting manner by reference to cytokine assays.
    Type: Application
    Filed: September 18, 2009
    Publication date: May 6, 2010
    Applicant: Singulex, Inc.
    Inventors: John Todd, Quynhanh Lu, Robert Freese
  • Patent number: 7572640
    Abstract: Disclosed are methods, kits, and compositions for the highly sensitive detection of molecules. The methods, kits, and compositions are useful in determining concentrations of molecules in samples to levels of 1 femtomolar, 1 attomolar, or lower. The methods, kits, and compositions also allow the determination of concentration over a wide range, e.g., 7-log range, without need for sample dilution.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: August 11, 2009
    Assignee: Singulex, Inc.
    Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held
  • Publication number: 20090159812
    Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.
    Type: Application
    Filed: December 18, 2008
    Publication date: June 25, 2009
    Applicant: SINGULEX, INC
    Inventor: Richard A. Livingston
  • Publication number: 20040166514
    Abstract: A method for detecting a target nucleic acid molecule or target nucleic acid molecular complex comprising: (a) contacting two or more probes complementary to the molecule or molecular complex, said molecule or molecular complex being labeled with one or more fluorescent dye molecules of the same dye or labeled with two dyes that are indistinguishable by their emission characteristics in an assay instrument, wherein each probe interacts specifically with a different target nucleic acid sequence or a structure on the molecule or molecular complex; and (b) detecting interaction of the probes with the molecule or molecular complex, said interaction being detected by an increase in fluorescence intensity during a detection interval having a fluorescence intensity above the fluorescence intensity of any individual free probe, wherein molecule or molecular complex is analyzed such that only individual molecules or molecular complexes in contact with a probe are within an interrogation volume and within a detection t
    Type: Application
    Filed: November 19, 2003
    Publication date: August 26, 2004
    Applicant: Singulex, Inc.
    Inventor: Robert Steven Puskas